SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma.

Jeong EJ, Kim YS, Lee Y, Ryu JS, Choi YH, Kim E

Open source

DOI
10.32604/or.2026.078376
Published
2026
Container
Oncology research
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.32604/or.2026.078376,
  title = {SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma.},
  author = {Jeong EJ and Kim YS and Lee Y and Ryu JS and Choi YH and Kim E},
  year = {2026},
  journal = {Oncology research},
  doi = {10.32604/or.2026.078376},
  url = {https://doi.org/10.32604/or.2026.078376}
}

RIS

TY  - JOUR
TI  - SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma.
AU  - Jeong EJ
AU  - Kim YS
AU  - Lee Y
AU  - Ryu JS
AU  - Choi YH
AU  - Kim E
PY  - 2026
JO  - Oncology research
DO  - 10.32604/or.2026.078376
UR  - https://doi.org/10.32604/or.2026.078376
ER  - 

APA

EJ, J., YS, K., Y, L., JS, R., YH, C., & E, K. (2026). SFXN3 Serves as a Predictive Biomarker for Cisplatin Response and Survival in Head and Neck Squamous Cell Carcinoma.. Oncology research. https://doi.org/10.32604/or.2026.078376

Source records